Pre-market hot trades in US stocks: L3Harris Tech up 7.50% in pre-market; Evolution Metals & Tech down 7.37% in pre-market

Pre-market Hot Trades in US Stocks L3Harris Tech is up 7.50% in pre-market trading. Based on recent key news: On January 5, L3Harris announced the sale of a 60% stake in its aerospace and propulsion business for over $500 million to AE Industrial Partners, retaining a 40% stake to refocus on its core national security business. This move further drives the company's strategic transformation, resulting in a rise in stock price. On January 5, L3Harris announced a restructuring of its business structure, reorganizing from four business units into three, including space and mission systems, communications and spectrum superiority, and missile solutions. The restructuring aims to improve operational efficiency and strategic focus, and the market reacted positively. On January 5, Benzinga's Edge Rankings placed L3 Harris in the high percentile for quality and momentum, reflecting its strong performance in these areas. Over the past year, L3 Harris stock has risen by 49.04%, further boosting investor confidence. The defense industry has performed strongly recently amid increasing geopolitical risks. Evolution Metals & Tech is down 7.37% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Top Gainers in Pre-market US Stocks ECD Automotive Design is up 36.41% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. CIMG is up 34.26% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Acrivon is up 23.39% in pre-market trading. Based on recent key news: On January 6, Acrivon Therapeutics released an important announcement that drove the stock price up. The company published original content through GlobeNewswire, with details being the company's responsibility, leading to market confidence in its future development, resulting in a pre-market stock price increase of 23.39%. Recent volatility in US stocks requires attention to risks